TERT and glioblastoma: Furthermore, in another study, in 55% of the 358 glioblastomas analyzed, TERT promoter mutations (C228T, C250T) were detected; of the 55%, 73% had a C228T mutation, and 27% had a C250T mutation; only one glioblastoma had both mutations [2].